guttitude logo

guttitude

early access
← Back to atlas
supportedmidhigh inflation risk

Bilophila wadsworthia

ulcerative colitis

Bilophila wadsworthia has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Bilophila wadsworthia shows a moderate evidence base in ulcerative colitis, with multiple central papers and additional supporting literature.

bilophila_wadsworthia
Credibility score
20
Human translation
2/5
Reproducibility
2/5
Novelty
4/5
Actionability
2/5
Credibility 20Human translation 2/5Reproducibility 2/5Novelty 4/5Actionability 2/5
Why this scores the way it does
  • moderate central evidence base
Main caveats
  • preclinical evidence outweighs human evidence

Internal review flags

1 flags
preclinical_heavy

Preclinical evidence exceeds central human evidence. Interpret translational relevance cautiously.

Primary central evidence

6 papers
Diversity and distribution of sulphate-reducing bacteria in human faeces from healthy subjects and patients with inflammatory bowel disease.
2012
FEMS immunology and medical microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
2021
MicrobiologyOpen
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
2023
EBioMedicine
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease.
2023
Journal of autoimmunity
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study.
2024
Microbial cell (Graz, Austria)
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Characteristics of gut microbiota and metabolites in patients with ulcerative colitis with fatigue.
2026
World journal of gastroenterology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.

Preclinical supporting evidence

9 papers
Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis.
2018
Journal of gastroenterology and hepatology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Three types of gut bacteria collaborating to improve Kui Jie'an enema treat DSS-induced colitis in mice.
2019
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Colonisation of the colonic mucus gel layer with butyrogenic and hydrogenotropic bacteria in health and ulcerative colitis.
2021
Scientific reports
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation.
2021
Food & function
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Effects of ShenLing BaiZhu San Supplementation on Gut Microbiota and Oxidative Stress in Rats with Ulcerative Colitis.
2021
Evidence-based complementary and alternative medicine : eCAM
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Nuciferine Regulates Immune Function and Gut Microbiota in DSS-Induced Ulcerative Colitis.
2022
Frontiers in veterinary science
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Polysaccharides from natural Cordyceps sinensis attenuated dextran sodium sulfate-induced colitis in C57BL/6J mice.
2023
Food & function
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Lactobacillus rhamnosus KBL2290 Ameliorates Gut Inflammation in a Mouse Model of Dextran Sulfate Sodium-Induced Colitis.
2023
Journal of microbiology (Seoul, Korea)
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Comparison of four characteristic carotenoids (lutein, β-carotene, lycopene, and astaxanthin) in alleviating DSS-induced colitis through gut microbiota regulation.
2025
Food & function
Disease-relevant preclinical or model-based paper useful as supporting evidence.

Review supporting evidence

1 papers
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study.
2025
Microorganisms
Relevant review or meta-analysis for the signal-disease area.